Forte Biosciences FBRX
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 27.27 | 61 | -34.17 | -25 | -27.56 | 83 |
| 2025Q3 | 15.00 | 84 | -19.36 | -18 | -17.26 | 97 |
| 2025Q2 | 12.93 | 99 | -16.42 | -11 | -14.49 | 108 |
| 2025Q1 | 7.76 | 38 | -34.44 | -16 | -28.72 | 47 |
| 2024Q4 | 22.71 | 52 | -23.14 | -7 | -18.00 | 62 |
| 2024Q3 | 5.59 | 9 | -63.75 | -8 | -38.12 | 18 |
| 2024Q2 | 13.43 | 17 | -54.82 | -13 | -43.07 | 26 |
| 2024Q1 | 17.41 | 29 | -23.19 | -7 | -20.90 | 32 |
| 2023Q4 | 20.54 | 35 | -15.51 | -6 | -13.52 | 39 |
| 2023Q3 | 16.55 | 40 | -30.49 | -10 | -25.18 | 48 |
| 2023Q2 | 26.00 | 25 | -30.76 | -9 | -26.21 | 31 |
| 2023Q1 | 25.25 | 33 | -18.82 | -7 | -17.16 | 37 |
| 2022Q4 | 25.00 | 39 | -11.95 | -5 | -11.20 | 42 |
| 2022Q3 | 26.75 | 43 | -8.39 | -3 | -8.01 | 45 |
| 2022Q2 | 32.50 | 38 | -7.76 | -3 | -7.49 | 40 |
| 2022Q1 | 36.50 | 40 | -6.29 | -3 | -6.07 | 41 |
| 2021Q4 | 53.50 | 42 | -7.84 | -3 | -7.37 | 43 |
| 2021Q3 | 74.00 | 44 | -16.57 | -8 | -15.46 | 47 |
| 2021Q2 | 840.50 | 50 | -11.11 | -6 | -10.57 | 53 |
| 2021Q1 | 856.75 | 55 | -8.45 | -5 | -8.12 | 57 |